![Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development of Therapies to Treat Muscular Dystrophies | Business Wire Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development of Therapies to Treat Muscular Dystrophies | Business Wire](https://mms.businesswire.com/media/20210623005126/en/1109787/23/Vita_Therapeutics_Logo.jpg)
Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development of Therapies to Treat Muscular Dystrophies | Business Wire
![Vita Therapeutics Closes $31 Million Series B Financing to Develop Cell Therapies for Neuromuscular Diseases and Cancers | Business Wire Vita Therapeutics Closes $31 Million Series B Financing to Develop Cell Therapies for Neuromuscular Diseases and Cancers | Business Wire](https://mms.businesswire.com/media/20221012005128/en/1392152/22/Vita_Therapeutics.jpg)
Vita Therapeutics Closes $31 Million Series B Financing to Develop Cell Therapies for Neuromuscular Diseases and Cancers | Business Wire
![Good News: Vita Therapeutics Raises $32M, 2 SIL Alums to Each Receive $225K in Funding, Johns Hopkins 5th in Patents Awarded and More - Johns Hopkins Technology Ventures Good News: Vita Therapeutics Raises $32M, 2 SIL Alums to Each Receive $225K in Funding, Johns Hopkins 5th in Patents Awarded and More - Johns Hopkins Technology Ventures](https://ventures.jhu.edu/wp-content/uploads/2020/09/Copy-of-Copy-of-Copy-of-Application-Announcement-300x200.png)
Good News: Vita Therapeutics Raises $32M, 2 SIL Alums to Each Receive $225K in Funding, Johns Hopkins 5th in Patents Awarded and More - Johns Hopkins Technology Ventures
![Baltimore Maryland based Vita Therapeutics is raising $20,000,000.00 in New Equity Investment. - intelligence360 Baltimore Maryland based Vita Therapeutics is raising $20,000,000.00 in New Equity Investment. - intelligence360](https://i0.wp.com/www.intelligence360.news/wp-content/uploads/2021/02/vita.jpg?fit=1200%2C560&ssl=1)
Baltimore Maryland based Vita Therapeutics is raising $20,000,000.00 in New Equity Investment. - intelligence360
![Maryland Inno - Baltimore startup Vita Therapeutics raises $31M to advance treatment for genetic diseases Maryland Inno - Baltimore startup Vita Therapeutics raises $31M to advance treatment for genetic diseases](https://media.bizj.us/view/img/12255209/microsoftteams-image-2*1600xx8192-4608-0-428.jpg)
Maryland Inno - Baltimore startup Vita Therapeutics raises $31M to advance treatment for genetic diseases
Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development o
![Vita Therapeutics Receives Orphan Drug Designation from FDA for Allogenic iPSC-based Therapy | BioInformant Vita Therapeutics Receives Orphan Drug Designation from FDA for Allogenic iPSC-based Therapy | BioInformant](https://bioinformant.com/wp-content/uploads/2020/07/Vita-Therapeutics.png)